laitimes

The number of shareholders of Jinkai Biotech decreased by 84, with an average shareholding of 98,800 yuan

author:Oriental Fortune Network
The number of shareholders of Jinkai Biotech decreased by 84, with an average shareholding of 98,800 yuan

On May 5, 2024, Jinkai Biotech disclosed in the interactive trading of the Shenzhen Stock Exchange that as of April 30, 2024, the number of shareholders of the company was 11,900, a decrease of 84 or 0.70% from the previous period (April 19, 2024).

The number of shareholders of Jinkai Biotech is lower than the industry average. According to Choice data, as of April 30, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry was 33,900. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 28.84%, and Jinkai Biotech is also in the range.

Distribution of the number of shareholders in the pharmaceutical and biological industry

The number of shareholders of Jinkai Biotech decreased by 84, with an average shareholding of 98,800 yuan

Number of shareholders and share price

Since March 31, 2024, the number of shareholders of the company has decreased for three consecutive periods, with a decrease of 5.44% so far. From March 31, 2024 to April 30, 2024, the stock price decreased by 7.77%.

Number of shareholders and share price

The number of shareholders of Jinkai Biotech decreased by 84, with an average shareholding of 98,800 yuan

Number of shareholders and share capital

As of April 30, 2024, the company's latest total share capital is 86,033,300 shares, of which the outstanding share capital is 21,508,300 shares. The latest average number of outstanding shares held by households was 1,810, a slight increase from the previous period, and the average market value of outstanding shares was 98,800 yuan.

The average amount of shares held by each household

The number of shareholders of Jinkai Biotech decreased by 84, with an average shareholding of 98,800 yuan

The market value of the circulating market held by Jinkai Biotech households is lower than the industry average. According to Choice data, as of April 30, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry was 400,300 yuan. Among them, 25.31% of the company's households hold a circulating stock market value in the range of 130,000~250,000.

Distribution of per capita circulating market value of the pharmaceutical and biological industry

The number of shareholders of Jinkai Biotech decreased by 84, with an average shareholding of 98,800 yuan

SZSE shareholdings

As of April 30, 2024, the number of shares held by SZSE was 313,400 shares, accounting for 0.36% of the outstanding share capital, an increase of 18.31% from 264,900 shares in the previous period (April 19, 2024).

SZSE shareholding chart

The number of shareholders of Jinkai Biotech decreased by 84, with an average shareholding of 98,800 yuan

Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.